Inhibition of the Tissue Factor-Thrombin Pathway Limits Infarct Size after Myocardial Ischemia-Reperfusion Injury by Reducing Inflammation-Reference-Cited by-同舟云学术

Inhibition of the Tissue Factor-Thrombin Pathway Limits Infarct Size after Myocardial Ischemia-Reperfusion Injury by Reducing Inflammation

Published:2000-12 Issue:6 Volume:157 Page:1849-1862
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Erlich Jonathan H.,Boyle Edward M.,Labriola Joanne,Kovacich J. Craig,Santucci Richard A.,Fearns Colleen,Morgan Elizabeth N.,Yun Wang,Luther Thomas,Kojikawa Osamu,Martin Thomas R.,Pohlman Timothy H.,Verrier Edward D.,Mackman Nigel

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference56 articles.

1. Progression of myocardial necrosis during reperfusion of ischemic myocardium;Matsumura;Circulation,1998

2. Inflammation in the course of early myocardial ischemia;Entman;FASEB J,1991

3. Cytokine mRNA expression in postischemic/reperfused myocardium;Herskowitz;Am J Pathol,1995

4. Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion;Ma;Circulation,1992

5. Thrombin potently stimulates cytokine production in human vascular smooth muscle cells but not in mononuclear phagocytes;Kranzhofer;Circ Res,1996

Cited by 189 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular disease and thrombosis: Intersections with the immune system, inflammation, and the coagulation system;Annales Pharmaceutiques Françaises;2024-08

2. Impact of Bivalirudin on Ischemia/Reperfusion Injury in Patients with Reperfused STEMI Assessed by Cardiac Magnetic Resonance;Pharmaceuticals;2024-02-01

3. Tissue Injury Protection: The Other Face of Anticoagulant Treatments in the Context of Ischemia and Reperfusion Injury with a Focus on Transplantation;International Journal of Molecular Sciences;2023-12-14

4. Snake Venom Components as Therapeutic Drugs in Ischemic Heart Disease;Biomolecules;2023-10-18

5. Coagulation factors II, V, VII, IX, X and XI and mortality – a cohort study;Research and Practice in Thrombosis and Haemostasis;2023-08